KalVista Pharmaceuticals
KALV
KALV
69 hedge funds and large institutions have $122M invested in KalVista Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less capital invested
Capital invested by funds: $244M → $122M (-$123M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
69
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$11.3M | |
| 2 | +$5.62M | |
| 3 | +$1.99M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.97M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.72M |
Top Sellers
| 1 | -$3.56M | |
| 2 | -$1.92M | |
| 3 | -$891K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$765K |
| 5 |
Public Sector Pension Investment Board (PSP Investments)
Montreal,
Quebec, Canada
|
-$584K |